1.Hepatitis C virus-induced hepatocellular carcinoma.
Nicolas GOOSSENS ; Yujin HOSHIDA
Clinical and Molecular Hepatology 2015;21(2):105-114
Hepatitis C virus (HCV) is a leading etiology of hepatocellular carcinoma (HCC). The interaction of HCV with its human host is complex and multilayered; stemming in part from the fact that HCV is a RNA virus with no ability to integrate in the host's genome. Direct and indirect mechanisms of HCV-induced HCC include activation of multiple host pathways such as liver fibrogenic pathways, cellular and survival pathways, interaction with the immune and metabolic systems. Host factors also play a major role in HCV-induced HCC as evidenced by genomic studies identifying polymorphisms in immune, metabolic, and growth signaling systems associated with increased risk of HCC. Despite highly effective direct-acting antiviral agents, the morbidity and incidence of liver-related complications of HCV, including HCC, is likely to persist in the near future. Clinical markers to selectively identify HCV subjects at higher risk of developing HCC have been reported however they require further validation, especially in subjects who have experienced sustained virological response. Molecular biomarkers allowing further refinement of HCC risk are starting to be implemented in clinical platforms, allowing objective stratification of risk and leading to individualized therapy and surveillance for HCV individuals. Another role for molecular biomarker-based stratification could be enrichment of HCC chemoprevention clinical trials leading to smaller sample size, shorter trial duration, and reduced costs.
Biomarkers, Tumor/genetics/metabolism
;
Carcinoma, Hepatocellular/*etiology
;
Hepacivirus/genetics/*pathogenicity
;
Hepatitis C/complications/pathology/virology
;
Humans
;
Liver Neoplasms/*etiology
;
Risk
2.The relationship between hepatocellular carcinoma recurrence and hepatitis B virus recurrence after liver transplantation.
Min-ru LI ; Shu-hong YI ; Chang-jie CAI ; Hui-min YI ; Yu-ling AN ; Min WEI ; Gui-hua CHEN
Chinese Journal of Hepatology 2011;19(4):271-274
OBJECTIVETo investigate the relationship between hepatocellular carcinoma (HCC) recurrence and hepatitis B virus (HBV) recurrence.
METHODSThe clinical data of 340 patients underwent liver transplantation due to HBV related end-stage liver disease and received long-term follow up in our hospital from Jan 2004 to Dec 2008 were retrospectively analyzed. All patients received nucleoside analogues therapy formally before entering into the waiting list and nucleoside analogues combined low-dose HBIG therapy during and after transplantation. Patients were regularly followed up at the outpatient, monitoring the HBV recurrence and survival. Multivariate Cox regression analysis was used to evaluate the risk factors for hepatitis recurrence.
RESULTS33 patients suffered from HBV recurrence post transplantation. The 1-, 3- and 5- year recurrence rates were 7.0%, 10% and 13% respectively. The median HBV recurrence time was 5 months (1-21 months). COX regression analysis revealed that risk factors for HBV recurrence were HCC (HR = 2.98; 95% CI 1.08-8.25; P < 0.05) and pre-transplantation HBV-DNA load over 5 log10 copies/ml (HR = 3.99; 95% CI 1.85-8.62; P < 0.01). Further stratified analysis showed that patients who suffered from carcinoma recurrence had a higher incidence of HBV recurrence than those who did not, which were 27.9% and 8.7% (HR = 4.58;95% CI 1.88-11.12; P < 0.01) respectively. 12 patients suffered from both HCC and HBV recurrence. Spearman correlation analysis demonstrated a strong correlation between HBV and HCC recurrence times (r = 0.583, P < 0.05).
CONCLUSIONSPost transplantation HCC recurrence is a risk factor for HBV recurrence.
Adult ; Carcinoma, Hepatocellular ; pathology ; virology ; Female ; Hepatitis B ; complications ; Hepatitis B virus ; Humans ; Liver Neoplasms ; pathology ; virology ; Liver Transplantation ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; etiology ; Retrospective Studies ; Risk Factors
3.Adeno-Associated Virus 2-Mediated Hepatocellular Carcinoma is Very Rare in Korean Patients.
Kyoung Jin PARK ; Jongan LEE ; June Hee PARK ; Jae Won JOH ; Choon Hyuck David KWON ; Jong Won KIM
Annals of Laboratory Medicine 2016;36(5):469-474
BACKGROUND: The incidence and etiology of hepatocellular carcinoma (HCC) vary widely according to race and geographic regions. The insertional mutagenesis of adeno-associated virus 2 (AAV2) has recently been considered a new viral etiology of HCC. The aim of this study was to investigate the frequency and clinical characteristics of AAV2 in Korean patients with HCC. METHODS: A total of 289 unrelated Korean patients with HCC, including 159 Hepatitis-B-related cases, 16 Hepatitis-C-related cases, and 114 viral serology-negative cases, who underwent surgery at the Samsung Medical Center in Korea from 2009 to 2014 were enrolled in this study. The presence of AAV2 in fresh-frozen tumor tissues was investigated by DNA PCR and Sanger sequencing. The clinical and pathological characteristics of AAV2-associated HCC in these patients were compared with previous findings in French patients. RESULTS: The AAV2 detection rate in Korean patients (2/289) was very low compared with that in French patients (11/193). Similar to the French patients, the Korean patients with AAV2-related HCC showed no signs of liver cirrhosis. The Korean patients were younger than the French patients with the same AAV2-associated HCC; the ages at diagnosis of the two Korean patients were 47 and 39 yr, while the median age of the 11 French patients was 55 yr (range 43-90 yr). CONCLUSIONS: AAV2-associated HCC was very rare in Korean patients with HCC. Despite a limited number of cases, this study is the first to report the clinical characteristics of Korean patients with AAV2-associated HCC. These findings suggest epidemiologic differences in viral hepatocarcinogenesis between Korean and European patients.
Adult
;
Asian Continental Ancestry Group
;
Capsid Proteins/genetics
;
Carcinoma, Hepatocellular/etiology/*pathology/virology
;
DNA, Viral/chemistry/genetics/metabolism
;
DNA-Binding Proteins/genetics
;
Dependovirus/*genetics/isolation & purification/pathogenicity
;
Female
;
Humans
;
Incidence
;
Inverted Repeat Sequences/genetics
;
Liver Neoplasms/etiology/*pathology/virology
;
Male
;
Middle Aged
;
Parvoviridae Infections/complications/epidemiology
;
Polymerase Chain Reaction
;
Republic of Korea
;
Sequence Analysis, DNA
;
Viral Proteins/genetics
4.Expression of the G1-S Modulators in Hepatitis B Virus-Related Hepatocellular Carcinoma and Dysplastic Nodule: Association of Cyclin D1 and p53 Proteins with the Progression of Hepatocellular Carcinoma.
Yoon La CHOI ; Seong Hoe PARK ; Ja June JANG ; Cheol Keun PARK
Journal of Korean Medical Science 2001;16(4):424-432
Deranged expression of cell cycle modulators has been reported to contribute to the development and progression of hepatocellular carcinoma (HCC). However, their expression patterns remain poorly understood in hepatitis B virus (HBV)-related HCC, which constitutes about 65-70% of HCC in Korea. The aims of this study were to evaluate the expressions of G1-S modulators in HBV-related HCCs and dysplastic nodules (DNs), and to correlate with the histopathologic features of HCCs. Immunohistochemical expressions of cyclin D1, cyclin E, p53, p27, p21, p16, Rb, and PCNA proteins were investigated in 80 HCCs and 22 DNs. Cyclin D1 overexpression showed positive relationships with advanced tumor stage, poor differentiation, larger tumor size, microvascular invasion, intrahepatic meta-stasis, no tumor capsule formation, infiltrative growth, aberrant p53 expression, and high PCNA labeling index (LI) of HCC (p<0.05). Aberrant p53 expression showed positive relationship with poor differentiation of HCC (p<0.01). Expression of cyclin D1 or p53 was not observed in DNs. The p27 LI and p16 LI were lower in HCCs with intrahepatic metastasis (p<0.05). Cyclin D1 overexpression and aberrant p53 expression could be associated with the progression of HBV-related HCC, and might have a less crucial role in the DN-HCC sequence. In addition, elevated expression of p27 and p16 proteins might have inhibitory action to the intrahepatic metastasis of HBV-related HCC.
Adult
;
Aged
;
Carcinoma, Hepatocellular/chemistry/etiology/*pathology
;
Cyclin D1/*analysis
;
Female
;
G1 Phase
;
Hepatitis B/*complications
;
Human
;
Immunohistochemistry
;
Liver Neoplasms/chemistry/etiology/*pathology
;
Male
;
Microfilament Proteins/analysis
;
Middle Age
;
Precancerous Conditions/*virology
;
Proliferating Cell Nuclear Antigen/analysis
;
Protein p16/analysis
;
Protein p53/*analysis
;
Retinoblastoma Protein/analysis
;
S Phase
5.Association of Polymorphism in MicroRNA 604 with Susceptibility to Persistent Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma.
Jae Youn CHEONG ; Hyoung Doo SHIN ; Sung Won CHO ; Yoon Jun KIM
Journal of Korean Medical Science 2014;29(11):1523-1527
MicroRNA polymorphisms may be associated with carcinogenesis or immunopathogenesis of infection. We evaluated whether the mircoRNA-604 (miR-604) polymorphism can affect the persistence of hepatitis B virus (HBV) infection, and the development to hepatocellular carcinoma (HCC) in patients with chronic HBV infection. A total of 1,439 subjects, who have either past or present HBV infection, were enrolled and divided into four groups (spontaneous recovery, chronic HBV carrier without cirrhosis, liver cirrhosis and HCC). We genotyped the precursor miR-604 genome region polymorphism. The CC genotype of miR-604 rs2368392 was most frequently observed and T allele frequency was 0.326 in all study subjects. The HBV persistence after infection was higher in those subjects with miR-604 T allele (P=0.05 in a co-dominant and dominant model), which implied that the patients with miR-604 T allele may have a higher risk for HBV chronicity. In contrast, there was a higher rate of the miR-604 T allele in the chronic carrier without HCC patients, compared to those of the HCC patients (P=0.03 in a co-dominant model, P=0.02 in a recessive model). The T allele at miR-604 rs2368392 may be a risk allele for the chronicity of HBV infection, but may be a protective allele for the progression to HCC in chronic HBV carriers.
Adult
;
Aged
;
Aged, 80 and over
;
Base Sequence
;
Carcinoma, Hepatocellular/etiology/*genetics/pathology
;
Case-Control Studies
;
Demography
;
Female
;
Gene Frequency
;
*Genetic Predisposition to Disease
;
Genotype
;
Hepatitis B Antibodies/blood
;
Hepatitis B Surface Antigens/blood
;
Hepatitis B e Antigens/blood
;
Hepatitis B virus/metabolism
;
Hepatitis B, Chronic/complications/*genetics/virology
;
Humans
;
Liver Neoplasms/etiology/*genetics/pathology
;
Male
;
MicroRNAs/*genetics/metabolism
;
Middle Aged
;
Polymorphism, Single Nucleotide
;
Risk Factors
6.Parvovirus B19-induced Pure Red Cell Aplasia in a Liver Transplant Recipient.
Eun Young LEE ; Yonggeun CHO ; Sang Guk LEE ; Jaewoo SONG
The Korean Journal of Laboratory Medicine 2010;30(6):591-594
Parvovirus B19 infection is known to cause chronic anemia in immunocompromised hosts, including organ transplant recipients. We report the first case of liver transplant recipient with parvovirus B19-induced pure red cell aplasia in Korea. A 57-yr-old female patient with hepatocellular carcinoma due to hepatitis C virus received a liver transplantation. Two months later, anemia developed and she received periodic red blood cell transfusions. However, chronic anemia persisted and bone marrow examination was performed 8 months after transplantation. Bone marrow aspiration smears showed markedly reduced erythroid precursors with atypical giant pronormoblasts and nuclear remnants with viral inclusions, and characteristic lantern cells were observed in biopsy sections. In addition, parvovirus B19 DNA PCR was positive. She was diagnosed as parvovirus B19-induced pure red cell aplasia and her anemia was improved following intravenous immunoglobulin therapy.
Blood Transfusion
;
Bone Marrow/pathology
;
Carcinoma, Hepatocellular/etiology/therapy
;
DNA, Viral/analysis
;
Female
;
Hepatitis C/complications/diagnosis
;
Humans
;
Immunocompromised Host
;
Immunoglobulins/therapeutic use
;
Liver Neoplasms/etiology/therapy
;
Liver Transplantation
;
Middle Aged
;
Parvoviridae Infections/complications/*diagnosis
;
*Parvovirus B19, Human/genetics
;
Red-Cell Aplasia, Pure/*diagnosis/therapy/virology
7.Association between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus.
Seun Joo AHN ; Dong Kyu KIM ; Soon Sun KIM ; Chang Bum BAE ; Hyo Jung CHO ; Han Gyeol KIM ; Young Jip KIM ; Joo Ho LEE ; Hyo Jin LEE ; Mi Yeon LEE ; Kee Bum KIM ; Jin Hee CHO ; Sung Won CHO ; Jae Youn CHEONG
Clinical and Molecular Hepatology 2012;18(3):295-301
BACKGROUND/AIMS: Apolipoprotein E (ApoE) plays an important role in regulating lipid and lipoprotein metabolism, and ApoE genotypes are known to affect plasma lipoprotein concentrations. We investigated whether ApoE genotype determines the disease outcome in hepatitis B virus (HBV)-infected individuals, and verified the association between ApoE genotype and the occurrence of hepatocellular carcinoma (HCC) in patients with chronic liver diseases of various etiologies. METHODS: This hospital-based, case-controlled study enrolled 156 subjects (47 healthy controls, 50 HBV-related liver cirrhosis patients, and 59 HCC patients). ApoE genotypes were determined using PCR-based ApoE genotyping kits. The biological significance of ApoE genotype was verified by measuring serum ApoE levels using an ELISA kits. RESULTS: The epsilon3 allele was the most common allele, with allele frequencies among the entire cohort of 5.8%, 84.3%, and 9.9% for the epsilon2, epsilon3, and epsilon4 alleles, respectively. Significantly more of those patients carrying the epsilon3/3 genotype had developed liver cirrhosis compared to the control subjects. Being an ApoE4 carrier was associated with a lower probability of developing liver cirrhosis. The allele frequencies and genotype distribution of ApoE did not differ significantly between the liver cirrhosis and HCC patients. The serum level of ApoE was significantly higher in patients with liver cirrhosis than in the healthy controls, but did not differ significantly with the ApoE genotype. CONCLUSIONS: The ApoE epsilon3/3 genotype frequency was higher in patients with HBV-associated liver cirrhosis than in the controls.
Adult
;
Aged
;
Aged, 80 and over
;
Alleles
;
Apolipoproteins E/*genetics/metabolism
;
Carcinoma, Hepatocellular/*metabolism/pathology
;
Case-Control Studies
;
Child
;
Chronic Disease
;
Cohort Studies
;
Female
;
Gene Frequency
;
Genotype
;
Hepatitis B/complications/metabolism/virology
;
Hepatitis B virus/*physiology
;
Humans
;
Liver Cirrhosis/etiology/*metabolism
;
Liver Neoplasms/*metabolism/pathology
;
Male
;
Middle Aged
;
Young Adult